Sinus histiocytosis with massive lymphadenopathy. A newly recognized benign clinicopathological entity.

897 indexed citations
published 1969
Journal
PubMed

In The Last Decade

doi.org/w86866799 →

Countries where authors are citing Sinus histiocytosis with massive lymphadenopathy. A newly recognized benign clinicopathological entity.

Specialization
Citations

This map shows the geographic impact of Sinus histiocytosis with massive lymphadenopathy. A newly recognized benign clinicopathological entity.. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Sinus histiocytosis with massive lymphadenopathy. A newly recognized benign clinicopathological entity. with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Sinus histiocytosis with massive lymphadenopathy. A newly recognized benign clinicopathological entity. more than expected).

Fields of papers citing Sinus histiocytosis with massive lymphadenopathy. A newly recognized benign clinicopathological entity.

Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of Sinus histiocytosis with massive lymphadenopathy. A newly recognized benign clinicopathological entity.. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the Sinus histiocytosis with massive lymphadenopathy. A newly recognized benign clinicopathological entity..

About Sinus histiocytosis with massive lymphadenopathy. A newly recognized benign clinicopathological entity.

This paper, published in 1969, received 897 indexed citations . Written by Juan Rosaí and R F Dorfman covering the research area of Immunology, Physiology and Pulmonary and Respiratory Medicine. It is primarily cited by scholars working on Physiology (847 citations), Infectious Diseases (638 citations) and Oncology (450 citations). Published in PubMed.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

This paper is also available at doi.org/w86866799.

Explore hit-papers with similar magnitude of impact

Rankless by CCL
2026